Voyager Stock: Neurocrine Deal Signals More Upside (NASDAQ:VYGR)

In trying to deliver breakthrough, Voyager is able to ink multiple robust deals with reputable companies. Read why the Neurocrine deal signals more upside for VYGR.

Related Keywords

Cambridge ,Cambridgeshire ,United Kingdom ,Massachusetts ,United States ,Warren Buffett ,Al Sandrock ,Jude Onyia , ,Integrated Biosci Investing ,Chief Scientific Officer ,